Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Amir Sonnenblick
Based on 19 articles published since 2009
(Why 19 articles?)
||||
Expertise Level
The expertise of Amir Sonnenblick ranks in the
  • Top 0.14%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 19 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Sonnenblick, Amir   ·   Sonnenblick, A
Work Locations
Details
Most likely:    Tel Aviv University      
2019
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Frontier Science, Kingussie, U.K. · Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Klinik für Gynäkologie und Geburtshilfe, Interdisziplinäres Brustzentrum, HELIOS Klinikum Berlin Buch, Berlin, Germany. · Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, U.K. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Western General Hospital, University of Edinburgh Cancer Research Centre, Edinburgh, U.K. · Deakin University, Waurn Ponds, VIC, Australia. · Breast International Group (BIG), Brussels, Belgium. · F. Hoffmann-La Roche, Basel, Switzerland. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Harvard Medical School, Boston, MA, U.S.A. · Academic Department of Biochemistry, Royal Marsden Hospital, London, U.K. · Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, U.S.A. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 30711959
2018
  • Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Oncology Department, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 30154156
Probable:    Tel Aviv Sourasky Medical Center      
2019
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Frontier Science, Kingussie, U.K. · Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Klinik für Gynäkologie und Geburtshilfe, Interdisziplinäres Brustzentrum, HELIOS Klinikum Berlin Buch, Berlin, Germany. · Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, U.K. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Western General Hospital, University of Edinburgh Cancer Research Centre, Edinburgh, U.K. · Deakin University, Waurn Ponds, VIC, Australia. · Breast International Group (BIG), Brussels, Belgium. · F. Hoffmann-La Roche, Basel, Switzerland. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Harvard Medical School, Boston, MA, U.S.A. · Academic Department of Biochemistry, Royal Marsden Hospital, London, U.K. · Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, U.S.A. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 30711959
2018
  • Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Oncology Department, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 30154156
Probable:    Hebrew University of Jerusalem      
2018
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • a Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center , Jerusalem , Israel. · b Department of Molecular Biology , Weizmann Institute of Science , Rehovot , Israel. · c Department of Developmental Biology and Cancer Research , Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School , Jerusalem , Israel. · d Institute of Pathology, Hadassah-Hebrew University Medical Center , Jerusalem , Israel. · Pubmed 29565707
2017
  • Amir Sonnenblick, Hadassah-Hebrew University Medical Center, Jerusalem, Israel · Dominique Agbor-Tarh and Ian Bradbury, Frontier Science, Kingussie, United Kingdom · Serena Di Cosimo Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy · Hatem A. Azim Jr, Martine Piccart-Gebhart and Evandro de Azambuja, Université Libre de Bruxelles · Debora Fumagalli, Breast International Group, Brussels, Belgium · Severine Sarp, Novartis Pharma AG, Basel, Switzerland · Antonio C. Wolff, Johns Hopkins School of Medicine, Baltimore, MD · Lyndsay Harris, Case Western Reserve University School of Medicine, Cleveland, OH · Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA · Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL · Michael Andersson, Rigshospitalet University Hospital Copenhagen, Denmark · Judith Kroep, Leiden University Medical Center, Leiden, the Netherlands · Tanja Cufer, University Clinic Golnik Medical Faculty, Ljubljana, Slovenia · Sergio D. Simon, Hospital Israelita Albert Einstein · Sergio D. Simon, Grupo Brasileiro de Estudos do Cancer de Mama, São Paulo, Brazil · Pamela Salman, Fundación Arturo López Pérez, Santiago, Chile · Masakazu Toi, Kyoto University, Kyoto, Japan · Maccon Keane, University Hospital Galway, Galway · and Maccon Keane, Cancer Trials Ireland, Dublin, Ireland. · Pubmed 28375706
  • Institute of Oncology, The Chaim Sheba Medical Center, Tel Hashomer, Israel. · Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel. · Pubmed 28120435
  • Sharett Institute, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Pubmed 28038446
2016
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. Electronic address: · Pubmed 27430154
2013
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Ein Kerem, P.O. Box 12000, Jerusalem, 91120, Israel. · Pubmed 23446809
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 19 total) written by Amir Sonnenblick about Breast Neoplasms:

  • Autoimmunity and Benefit from Trastuzumab Treatment in Breast Cancer: Results from the HERA Trial. 2019
  • p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial. 2018
  • Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification. 2018
  • Ev vivo organ culture as potential prioritization tool for breast cancer targeted therapy. 2018
  • Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial. 2017
  • Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer. 2017
  • Heparanase augments insulin receptor signaling in breast carcinoma. 2017
  • Metastatic breast cancer: The Odyssey of personalization. 2016
  • Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial. 2016
  • Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance. 2016
Show List of Full Article Records
Google Searches

Learn more about Amir Sonnenblick using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Tel Aviv University
Tel Aviv Sourasky Medical Center
Hebrew University of Jerusalem
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Tel Aviv University
2019
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Frontier Science, Kingussie, U.K. · Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Klinik für Gynäkologie und Geburtshilfe, Interdisziplinäres Brustzentrum, HELIOS Klinikum Berlin Buch, Berlin, Germany. · Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, U.K. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Western General Hospital, University of Edinburgh Cancer Research Centre, Edinburgh, U.K. · Deakin University, Waurn Ponds, VIC, Australia. · Breast International Group (BIG), Brussels, Belgium. · F. Hoffmann-La Roche, Basel, Switzerland. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Harvard Medical School, Boston, MA, U.S.A. · Academic Department of Biochemistry, Royal Marsden Hospital, London, U.K. · Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, U.S.A. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 30711959
2018
  • Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Oncology Department, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 30154156
Tel Aviv Sourasky Medical Center
2019
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Frontier Science, Kingussie, U.K. · Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Klinik für Gynäkologie und Geburtshilfe, Interdisziplinäres Brustzentrum, HELIOS Klinikum Berlin Buch, Berlin, Germany. · Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, U.K. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Western General Hospital, University of Edinburgh Cancer Research Centre, Edinburgh, U.K. · Deakin University, Waurn Ponds, VIC, Australia. · Breast International Group (BIG), Brussels, Belgium. · F. Hoffmann-La Roche, Basel, Switzerland. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Harvard Medical School, Boston, MA, U.S.A. · Academic Department of Biochemistry, Royal Marsden Hospital, London, U.K. · Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, U.S.A. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 30711959
2018
  • Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Oncology Department, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 30154156
Hebrew University of Jerusalem
2018
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • a Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center , Jerusalem , Israel. · b Department of Molecular Biology , Weizmann Institute of Science , Rehovot , Israel. · c Department of Developmental Biology and Cancer Research , Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School , Jerusalem , Israel. · d Institute of Pathology, Hadassah-Hebrew University Medical Center , Jerusalem , Israel. · Pubmed 29565707
2017
  • Amir Sonnenblick, Hadassah-Hebrew University Medical Center, Jerusalem, Israel · Dominique Agbor-Tarh and Ian Bradbury, Frontier Science, Kingussie, United Kingdom · Serena Di Cosimo Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy · Hatem A. Azim Jr, Martine Piccart-Gebhart and Evandro de Azambuja, Université Libre de Bruxelles · Debora Fumagalli, Breast International Group, Brussels, Belgium · Severine Sarp, Novartis Pharma AG, Basel, Switzerland · Antonio C. Wolff, Johns Hopkins School of Medicine, Baltimore, MD · Lyndsay Harris, Case Western Reserve University School of Medicine, Cleveland, OH · Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA · Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL · Michael Andersson, Rigshospitalet University Hospital Copenhagen, Denmark · Judith Kroep, Leiden University Medical Center, Leiden, the Netherlands · Tanja Cufer, University Clinic Golnik Medical Faculty, Ljubljana, Slovenia · Sergio D. Simon, Hospital Israelita Albert Einstein · Sergio D. Simon, Grupo Brasileiro de Estudos do Cancer de Mama, São Paulo, Brazil · Pamela Salman, Fundación Arturo López Pérez, Santiago, Chile · Masakazu Toi, Kyoto University, Kyoto, Japan · Maccon Keane, University Hospital Galway, Galway · and Maccon Keane, Cancer Trials Ireland, Dublin, Ireland. · Pubmed 28375706
  • Institute of Oncology, The Chaim Sheba Medical Center, Tel Hashomer, Israel. · Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel. · Pubmed 28120435
  • Sharett Institute, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Pubmed 28038446
2016
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. Electronic address: · Pubmed 27430154
2013
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Ein Kerem, P.O. Box 12000, Jerusalem, 91120, Israel. · Pubmed 23446809
Jules Bordet Institute
2016
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. Electronic address: · Pubmed 27430154
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Translational Breast Cancer Laboratory, Free University of Brussels, Institute Jules Bordet, Brussels, Belgium. · GBG German Breast Group, Neu Isenburg, Germany. · Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · Multidisciplinary Breast Center, KU Leuven, University Hospitals, Leuven, Belgium. · Department of Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27172896
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
2015
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25712461
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
2014
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. Electronic address: · Pubmed 25151406
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
Universite Libre de Bruxelles
2016
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. Electronic address: · Pubmed 27430154
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
2015
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25712461
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
2014
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. Electronic address: · Pubmed 25151406
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
11 Other Locations Show
Yearly article counts 13345210000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.